It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 | Mumbai, Maharashtra, India | ActiveSnehal International Pharma Private Limited, a active private limited company, was established on 04 September 2020 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24290MH2020PTC345294. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Mrudula Sudhir Deulgaonkar (Director), Sudhir Ravindra Deulgaonkar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-101, Flr- 1St,Plot No.163E,Vasant Kunj Dr. Babasaheb Ambedkar Road, Dadar(E), Mumbai, Maharashtra, 400014.
U24290MH2020PTC345294
345294
04 September 2020
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Snehal International Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mrudula Sudhir Deulgaonkar | Director | 04 Sep 2020 | Current |
| Sudhir Ravindra Deulgaonkar | Director | 04 Sep 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Snehal International Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2031.81% increase in profit. The company's net worth Soared by an impressive increase of 334.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Snehal International Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Snehal International Pharma has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Snehal International Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snehal International Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Snehal International Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Snehal International Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Mrudula Sudhir Deulgaonkar was appointed as a Director was appointed as a Director on 04 Sep 2020 & has been associated with this company since 5 years 3 months . was documented.
Sudhir Ravindra Deulgaonkar was appointed as a Director was appointed as a Director on 04 Sep 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on Snehal International Pharma Private Limited was registered on 04 Sep 2020 with Roc Mumbai & aged 5 years 3 months as per MCA records. was documented.
The CIN of Snehal International Pharma Private Limited is U24290MH2020PTC345294.
Snehal International Pharma Private Limited is headquartered at E-101, Flr- 1St,Plot No.163E,Vasant Kunj Dr. Babasaheb Ambedkar Road, Dadar(E), Mumbai, Maharashtra, 400014.
Snehal International Pharma Private Limited was incorporated on 04 September 2020.
The current directors of Snehal International Pharma Private Limited are
The primary industry of Snehal International Pharma Private Limited is Pharma.
Snehal International Pharma Private Limited is unlisted.
The authorized capital of Snehal International Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX